2,023
Total Claims
$320K
Drug Cost
186
Beneficiaries
$1,723
Cost/Patient
Peer Comparison vs. 8,961 Nephrology providers
+34%
Cost per patient vs peers
$1,723 vs $1,283 avg
+217%
Brand preference vs peers
28.4% vs 9.0% avg
Brand vs Generic
72% generic
Brand: 566 claims · $229K
Generic: 1,429 claims · $91K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 109 | $81K |
| Sodium Zirconium Cyclosilicate | 111 | $62K |
| Sevelamer Carbonate | 205 | $38K |
| Lanthanum Carbonate | 81 | $29K |
| Calcium Acetate | 201 | $14K |
| Finerenone | 18 | $11K |
| Insulin Glargine,hum.Rec.Anlog | 31 | $9,887 |
| Apixaban | 12 | $6,824 |
| Insulin Regular, Human | 15 | $2,324 |
| Sodium Polystyrene Sulfonate | 30 | $2,285 |
| Candesartan Cilexetil | 30 | $2,270 |
| Chlorthalidone | 37 | $1,707 |
| Telmisartan | 44 | $1,702 |
| Levothyroxine Sodium | 16 | $1,632 |
| Bumetanide | 35 | $986 |
Prescribing Profile
38
Unique Drugs
Patient Profile
70
Avg Age
36%
Female
5.52
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About